OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
Conference | AOA
Justin Schweitzer, OD, shares key highlights from his presentation titled, "The OD's Role in the Management of MIGS in 2022," where he explores earlier intervention for glaucoma patients.
Optometry Times'® Kassi Jackson talks with Justin Schweitzer, OD, optometric externship director with Vance Thompson Vision in Sioux Falls, South Dakota, and one of the associate directors of the optometric residency program at Vance Thompson Vision, about his presentation titled, "The OD's Role in the Management of MIGS in 2022," which he is presenting during this year's AOA annual meeting in Chicago.
"Optometry, in general, needs to be involved in thinking about managing patients with minimally invasive glaucoma procedures," Schweitzer said.
Though ODs aren't the ones performing MIGS procedures, he said the terminology he thinks about is "interventional glaucoma" and how to intervene earlier in the disease process of glaucoma patients.
"By the year 2030, there's going to be about 4.1 million Americans with glaucoma; and by the year 2050, there's going to be about 6.3 million Americans with glaucoma," Schweitzer said.
Presbyopia: Revolutionary research lines
Cryosurgery: Available, efficient, and cost-effective for patients
AMD: What to look for and how to deal with It
The whens and hows of correcting refractive errors in infants and children